Log in to search using one of your social media accounts:

 

Assessing the Cutaneous Side Effects of Melanoma Drugs
(MedPage Today) -- Dermatologists need'hands on'experience (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 24, 2017 Category: Hematology Source Type: news

Medical News Today: Nine ways to raise blood pressure
If a person's blood pressure is too low, it can potentially be dangerous if left unaddressed. We look at nine ways to safely raise blood pressure. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 24, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

First Immunotherapy Approved for Gastric Cancer First Immunotherapy Approved for Gastric Cancer
Pembrolizumab is now indicated for third-line treatment of gastric or gastroesophageal junction cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Palliative Care Curbs Depression and Trauma in HSCT Patients Palliative Care Curbs Depression and Trauma in HSCT Patients
A brief, inpatient palliative care intervention reduced both depression and PTSD symptoms in patients undergoing hematopoietic stem cell transplant (HSCT), with sustained effects at 6 months.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Anemia rash: Symptoms, images, and treatment
Anemia rash is a term that refers to red pinpricks that appear on the skin and are caused by a low platelet count. We look at symptoms and treatments. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 22, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Egg Freezing May Not Delay Chemo for Breast Cancer Patients Egg Freezing May Not Delay Chemo for Breast Cancer Patients
Women diagnosed with breast cancer who want to freeze their eggs and embryos before tumor treatment leads to infertility can do this without delaying the start of chemotherapy, a U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 21, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UK Backs Opdivo for Lung Cancer After Bristol-Myers Cuts Price UK Backs Opdivo for Lung Cancer After Bristol-Myers Cuts Price
Bristol-Myers Squibb's immunotherapy drug Opdivo has been recommended for some patients with lung cancer by Britain's healthcare cost watchdog NICE after the drugmaker agreed a discounted price.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 21, 2017 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Cervical Ca Screening Rates Fall at Title X-Funded Clinics
(MedPage Today) -- Largest drops followed major updates to testing guidelines (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 21, 2017 Category: Hematology Source Type: news

New Guidelines for Managing CAR T-Cell Acute Toxicities New Guidelines for Managing CAR T-Cell Acute Toxicities
Researchers at MD Anderson have developed a framework to help recognize and manage unique acute toxicities associated with CAR T-cell therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Do Tattoos Raise the Risk for Cancer? Do Tattoos Raise the Risk for Cancer?
Components of the ink in tattoos migrate from the skin to the lymph nodes, leading to chronic enlargement, but the health risk has yet to be determined.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 21, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nipple-sparing Mastectomy Safe for Women With BRCA Mutations Nipple-sparing Mastectomy Safe for Women With BRCA Mutations
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 20, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news

In Breast Cancer, a Victory for Common Sense In Breast Cancer, a Victory for Common Sense
An ambitious randomized clinical neither accrued its planned number of patients nor met its expected events but has changed cancer care anywayMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 20, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Biosimilar Cancer Drug Threat Closing in for Roche Biosimilar Cancer Drug Threat Closing in for Roche
The long-heralded threat of cut-price competition to its top-selling biological cancer medicines is finally becoming a reality for Roche, the world's biggest maker of oncology treatments.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Imatinib a Double-Edged Sword for Pregnant CML Patients Imatinib a Double-Edged Sword for Pregnant CML Patients
On the one hand, imatinib keeps the CML in check; on the other hand, it carries a risk for fetal congenital malformation if taken during pregnancy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Futile: Prostate Cancer Vaccine Phase 3 Trial Ends Futile: Prostate Cancer Vaccine Phase 3 Trial Ends
Prostvac is an immunotherapy designed to induce T-cell responses and thus kill prostate cancer cells. As a monotherapy, it is not effective.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

5T4-targeted Immunotherapy Promising in Metastatic Colorectal Cancer 5T4-targeted Immunotherapy Promising in Metastatic Colorectal Cancer
Immunotherapy with modified vaccinia Ankara-5T4 (MVA-5T4, TroVax) may improve survival in patients with metastatic colorectal cancer, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New Path for Lung Cancer Treatment?
(MedPage Today) -- Targeting inflammation linked to fewer lung cancer deaths (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 18, 2017 Category: Hematology Source Type: news

Severe Health Problems Plague Survivors of Childhood CA Severe Health Problems Plague Survivors of Childhood CA
Specialized healthcare delivery is needed for diverse subgroups of adult cancer survivors with complex medical needs, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Big Alcohol' Deliberately Downplays Cancer Risk'Big Alcohol' Deliberately Downplays Cancer Risk
Global alcohol producers are downplaying the cancer risks associated with drinking in order to protect profits, just like tobacco firms did, say public health experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: How to stop bleeding: Eight effective home remedies
In this article, learn about eight effective home remedies to stop bleeding, including tea, ice, and mouthwash. How can infection be prevented? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 17, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

10 Questions to Challenge Your Medical News Savvy
(MedPage Today) -- Weekly News Quiz: September 8-14 (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 17, 2017 Category: Hematology Source Type: news

More Than Okay to Reduce Sorafenib Dose for Liver Cancer More Than Okay to Reduce Sorafenib Dose for Liver Cancer
Initially reducing the dosage of the oral therapy did not compromise overall survival in hepatocellular carcinoma and had important benefits.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

EU Panel Likes an Array of Cancer Products EU Panel Likes an Array of Cancer Products
The Committee for Medicinal Products for Human Use recommended granting marketing authorization to branded, generic, and biosimiliar products.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Medical News Today: Hyperemia: Causes, symptoms, and treatment
What is hyperemia? In this article, learn about the different types of hyperemia, including passive and active hyperemia. How can it be prevented? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 15, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Phosphate Disease Yields to Burosumab (CME/CE)
(MedPage Today) -- Both adults and children with X-linked hypophosphatemia benefited from monoclonal antibody treatment (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 14, 2017 Category: Hematology Source Type: news

New Drug Approved for Relapsed Lymphoma: Copanlisib New Drug Approved for Relapsed Lymphoma: Copanlisib
Patients with follicular lymphoma who have relapsed after at least two prior therapies now have a new option.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

First Oncology Biosimilar Approved in US: Bevacizumab First Oncology Biosimilar Approved in US: Bevacizumab
The FDA has approved the first biosimilar for use in the treatment of cancer: Myasi, or bevacizumab-awwb (equivalent to Avastin).News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

$45 Million for Patients Harmed by Disgraced Breast Surgeon $45 Million for Patients Harmed by Disgraced Breast Surgeon
The private healthcare company that employed disgraced breast cancer surgeon Ian Paterson, who is now in jail, will pay compensation to his patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Marital Status, Gender Tied to RCC T and Outcomes: Clin Onc News Report
(MedPage Today) -- Also, new AUA guidelines for handling localized renal masses (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 14, 2017 Category: Hematology Source Type: news

Marital Status, Gender Tied to RCC Tx and Outcomes: Clin Onc News Report
(MedPage Today) -- Also, new AUA guidelines for handling localized renal masses (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 13, 2017 Category: Hematology Source Type: news

Global Mesothelioma Deaths Remain High Despite Poor Data
An estimated 38,400 people around the world will die this year from mesothelioma cancer, according to a report recently published in Occupational & Environmental Medicine. The estimation by the international peer-reviewed journal included 230 countries. Data used for the study came from the World Health Organization’s (WHO) Mortality Database and extrapolated information based on gender- and age-specific death rates. “The global burden of mesothelioma is real,” Dr. Ken Takahashi, director of Asbestos Diseases Research Institute, University of Sydney Gate 3, Australia, told Asbestos.com. “It is v...
Source: Asbestos and Mesothelioma News - September 13, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Asbestos Diseases Research Institute asbestos-related lung cancer Australia mesothelioma Bangladesh Dr. Christina Fitzmaurice Dr. Ken Takahashi Global Burden of Disease Mesothelioma death rate mesothelioma latency period mesothelioma uni Source Type: news

Nivolumab-Ipilimumab Combo for Melanoma: 3-Year Survival Data Nivolumab-Ipilimumab Combo for Melanoma: 3-Year Survival Data
Three-year survival rates with advanced melanoma are 52% with nivolumab and 34% with ipilimumab, but 58% with a sequential combination of the two, according to the latest results comparing the two anticancer biologics separately and together.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

USPSTF Has New Draft Guidance for Cervical Cancer Screening USPSTF Has New Draft Guidance for Cervical Cancer Screening
The only major change is that the USPSTF no longer recommends testing in women 30 years and older.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA Extends Holds in Immunotherapy Trials in Blood Cancers FDA Extends Holds in Immunotherapy Trials in Blood Cancers
The Food and Drug Administration has slowed or fully halted more trials of immunotherapies in multiple myeloma and other blood cancersMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ASCO Issues Guidelines on Patient-Clinician Communication ASCO Issues Guidelines on Patient-Clinician Communication
New guidelines from the American Society of Clinical Oncology (ASCO) offer strategies and recommendations for improving patient-clinician communication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

36% Price Drop With a Generic Oral Chemo: Good Enough? 36% Price Drop With a Generic Oral Chemo: Good Enough?
Capecitabine was one of the first oral chemotherapies to come off patent, and the generic version has been quickly accepted.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New Adjuvant Option for BRAF Melanoma New Adjuvant Option for BRAF Melanoma
Combined targeting with BRAF and MEK inhibitors will soon move into the adjuvant setting for treating BRAF-V300-positive stage III melanoma, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Clear Benefit With Adjuvant Nivolumab in Resected Melanoma Clear Benefit With Adjuvant Nivolumab in Resected Melanoma
Adjuvant nivolumab significant improves relapse-free survival and reduces toxicity in comparison with ipilimumab in stage III/IV resected melanoma for patients at risk for relapse, trial results reveal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Advantages and disadvantages of donating blood
In this article, learn about the advantages and disadvantages of donating blood, including how it affects the body, how the process works, and preparation. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 12, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Queens Medical Associates Shares Insight on Pain for Pain Awareness...
Queens oncology and hematology center provides tips on finding pain relief(PRWeb September 12, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14687540.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 12, 2017 Category: Pharmaceuticals Source Type: news

Expert Perspectives: ESMO 2017 Changes Lung Cancer Practice Expert Perspectives: ESMO 2017 Changes Lung Cancer Practice
Several lung cancer experts from the US and Europe provide their perspective on a variety of important lung trials presented at ESMO 2017.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Neurologic AEs on Rise as Checkpoint Inhibitors Evolve Neurologic AEs on Rise as Checkpoint Inhibitors Evolve
Potentially lethal immune-related adverse events (AEs) are expected to increase as anti-PD-1 therapies for solid tumors expand to include other cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

R & D Investment Does Not Justify High Cost of Cancer Drugs R & D Investment Does Not Justify High Cost of Cancer Drugs
A new analysis found that the revenue from cancer drugs greatly exceeds the investment to develop them.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

R and D Investment Does Not Justify High Cost of Cancer Drugs R and D Investment Does Not Justify High Cost of Cancer Drugs
A new analysis found that the revenue from cancer drugs greatly exceeds the investment to develop them.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Hint of Survival Gain With Ramucirumab in Urothelial Cancer Hint of Survival Gain With Ramucirumab in Urothelial Cancer
Patients with progressive urothelial cancer after platinum-based chemotherapy may benefit with the antiangiogenesis drug ramucirumab, although the absolute gain is small, trial results suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cancer Patients Struggle to Understand Clinical Trials Cancer Patients Struggle to Understand Clinical Trials
A nationwide study of cancer patients in Ireland found that many did not understand concepts of randomization or clinical equipoise, even when they had participated.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Abemaciclib: First-Line CDK4/6 Inhibitor for Breast Cancer Abemaciclib: First-Line CDK4/6 Inhibitor for Breast Cancer
Abemaciclib, the third CDK4/6 inhibitor, in combination with endocrine therapy shows significant benefit for the first-line treatment of HR+ HER2- advanced breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Chemoradiotherapy Remains Standard of Care in Cervical Cancer Chemoradiotherapy Remains Standard of Care in Cervical Cancer
Chemoradiotherapy remains the standard of care for cervical cancer patients with locally advanced disease, concludes an Indian trial that compared it to neoadjuvant chemotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Morning Break: Irma and Labor; Eclipse Eye Damage; Ditching Prescriptions
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 11, 2017 Category: Hematology Source Type: news

Immunotherapy Changes First-Line Paradigm in Advanced RCC Immunotherapy Changes First-Line Paradigm in Advanced RCC
For the first time, sunitinib has been beaten in a phase 3 trial; the combination of nivolumab and ipilimumab showed a significant improvement in overall survival.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news